Enhanced susceptibility of pentylenetetrazole kindled mice to quinolone effects

International Journal of Antimicrobial Agents

Volumn 12, Issue 3, 1999, Pages 239-244

  De Sarro, Angela ^a   Naccari, Francesco ^b   De Sarro, Giovambattista ^c  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Epilepsy; Kindling; Mice; Pentylenetetrazole; Quinolones; Seizures

Indexed keywords

CINOXACIN; CIPROFLOXACIN; NALIDIXIC ACID; OFLOXACIN; PENTETRAZOLE; QUINOLONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; EPILEPSY; INTRAPERITONEAL DRUG ADMINISTRATION; KINDLING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CONVULSANTS; GABA ANTAGONISTS; KINDLING, NEUROLOGIC; MALE; MICE; MICE, INBRED ICR; PENTYLENETETRAZOLE; QUINOLINES; SEIZURES;

EID: 0032769432     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00067-9     Document Type: Article

References (36)

1. Christ W. Central nervous system toxicity of quinolones: human and animal findings. J Antimicrob Chemother 1990;26:219-25.
2. Lucet IC, Tilly H, Lerebours G, Gres IL, Piguet H. Neurological toxicity related to pefloxacin. J Antimicrob Chemother 1988;21:811-2.
3. De Sarro A, De Sarro GB. Responsiveness of genetically epilepsy-prone rats to aminophylline-induced seizures and interactions with quinolones. Neuropharmacology 1991;30:169-76.
4. De Sarro A, Trimarchi GR, Ammendola D, De Sarro G. Repeated treatment with quinolones potentiates the seizures induced by aminophylline in genetically epilepsy-prone rats. Gen Pharmacol 1992;23:853-9.
5. De Sarro A, Zappalà M, Chimirri A, Grasso S, De Sarro GB. Quinolones potentiate cefazolin induced seizures in DBA/2 mice. Antimicrob Agents Chemother 1993;37:1497-503.
6. De Sarro A, Ammendola D, De Sarro GB. Effects of some quinolones on imipenem-induced seizures in DBA/2 mice. Gen Pharmac 1994;25:369-79.
7. Akahane K, Sekiguchi M, Une T, Osada Y. Structure-epileptogenicity relationship of quinolones with special reference to their interaction with γ-aminobutyric acid receptor sites. Antimicrob Agents Chemother 1989;33:1704-7.
8. Tsuji A, Sato H, Kume Y, et al. Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes. Antimicrob Agents Chemother 1988;32:190-4.
9. Unseld E, Ziegler G, Gemeinhardt A, Janssen U, Klotz U. Possible interaction of fluoroquinolones with the benzodiazepine-GABAA-receptor complex. Br J Cl Pharmacol 1990;30:63-70.
10. Ramanjaneyulu R, Ticku MK. Interaction of pentamethylenetetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine-GABA receptor-ionophore complex. Eur J Pharmacol 1984;98:337-45.
11. Squires RF, Saederup E, Grawley JN, Skolnick P, Paul SM. Convulsant potencies of tetrazole are highly correlated with action on GABA/picrotoxin receptor complexes in brain. Life Sci 1984;35:1439-44.
12. Enginar N, Eroglu L. The effect of ofloxacin and ciprofloxacin on pentylenetetrazol induced convulsions in mice. Pharmacol Biochem Behav 1991;39:587-9.
13. De Sarro A., Naccari F., Cecchetti V., Tabarrini O., De Sarro G.B., Proconvulsant effects of classic and novel desfluoroquinolones in mice. Abstract No. 103, 2nd European Congress of Chemotherapy, Hamburg, 10-13 May 1998.
14. 1A receptors. J Pharmacol Exp Ther 1991;257:1146-53.
15. Goddar GV. Development of epileptic seizures through brain stimulation at low intensity. Nature 1967;214:1020-1.
16. Piredda S, Yonekawa W, Whittingham TS, Kupferberg HJ. Enhanced bursting activity in the CA3 region of the mouse hippocampal slice without long-term potentiation in the dentate gyrus after systemic pentylenetetrazol kindling. Exp Neurol 1986;94:659-69.
17. Schmidt J. Changes in seizure susceptibility in rats following chronic administration of pentylenetetrazol. Biomed Biochim Acta 1987;46:267-70.
18. Karler R, Murphy V, Calder LD, Turkanis SA. Pentylenetetrazol kindling in mice. Neuropharmacology 1989;28:775-80.
19. McNamara JO. The neurobiological basis of epilepsy. Trends Neurosci 1992;10:357-9.
20. Cecchetti V, Fravolini A, Palumbo M, et al. Potent 6-desfluoro-8-methylquinolones as a new lead compounds in antibacterial chemotherapy. J Med Chem 1996;39:4952-7.
21. Racine R. Kindling: the first decade. Neurosurgery 1978;3:234-52.
22. Loscher W, Schwark WS. Further evidence for abnormal GABAergic circuits in amygdala-kindled rats. Brain Res 1987;420:385-90.
23. Peterson DW, Collins JF, Bradford HF. The kindled amygdala model of epilepsy: anticonvulsant action of amino acid antagonists. Brain Res 1983;275:169-72.
24. Mody I, Heinemann U. NMDA receptors of dentate gyrus granule cells participate in synaptic transmission following kindling. Nature 1987;326:701-4.
25. 2+ -dependent L-glutamate release in regio inferior of rat hippocampus. Brain Res 1990;508:188-93.
26. Kraus JE, Yeh GC, Bonhaus DW, Nadler JV, McNamara JO. Kindling induces the long-lasting expression of a novel population of NMDA receptors in hippocampal region CA3. J Neurosci 1994;14:4196-205.
27. Rocha L, Ackermann RF, Engel J. Chronic and single administration of pentylenetetrazol modifies benzodiazepine receptor-binding: an autoradiographic study. Epilepsy Res 1996;24:65-72.
28. Rocha L, Briones M, Ackermann RF, et al. Pentylenetetrazol-induced kindling: early involvement of excitatory and inhibitory systems. Epilepsy Res 1996;26:105-13.
29. Dazzi L, Serra M, Porceddu ML, Sanna A, Chessa MF, Biggio G. Enhancement of basal and pentylenetetrazol (PTZ)-stimulated dopamine release in the brain of freely moving rats by PTZ-induced kindling. Synapse 1997;26:351-8.
30. Serra M, Dazzi L, Cagetti M, et al. Effect of pentylenetetrazole-induced kindling on acetylcholine release in the hippocampus of freely moving rats. J Neurochem 1997;68:313-8.
31. De Sarro G, Nava F, Calapai G, De Sarro A. Effects of some excitatory amino acid antagonists and drugs enhancing γ-aminobutyric acid-stimulatory transmission on pefloxacin-induced seizures in DBA/2 mice. Antimicrob Agents Chemother 1997;41:427-34.
32. Dimpfel W, Spuler M, Dalhoff A, Hoffman W, Schluter G. Hippocampal activity in the presence of quinolones and fenbufen in vitro. Antimicrob Agents Chemother 1991;35:1142-6.
33. Dimpfel W, Dalhoff A, Von Keutz E. In vitro modulation of hippocampal pyramidal cell response by quinolones: effects of HA966 and γ-hydroxybutyric acid. Antimicrob Agents Chemother 1996;40:2573-6.
34. Akahane K, Kato M, Takayama S. Involvement of inhibitory and excitatory neurotransmitters in levofloxacin- and ciprofloxacin-induced convulsions in mice. Antimicrob Agents Chemother 1993;37:1764-70.
35. Dodd PR, Davies LP, Warson WEJ, et al. Neurochemical studies on quinolone antibiotics: effects on glutamate, GABA and adenosine systems in mammalian CNS. Pharmacol Toxicol 1989;64:404-11.
36. Geinisman Y, Morrell F, De Toledo-Morrell L. Remodeling of synaptic architecture during hippocampal 'kindling'. Proc Natl Acad Sci USA 1988;85:3260-4.